Abstract:OBJECTIVE: When preliminary tests have confirmed a nano-hydroxyapatite (Nano-HA) content of 20% of the polylactic acid (PLA) composite material of Nano-HA interface fixation material for biomechanical requirements, there is a need for further observation of its biocompatibility and clinical applications, to provide reference data.METHODS: Preparation of Nano-HA content of 20% PLA composite Nano-HA bone substitute material and extract. The establishment of the negative control group (containing 10% fetal bovine serum in DMEM complete medium), experimental group (extract), the positive control group (mass concentration of 0.64% phenol), and a co-culture of rabbit bone marrow mesenchymal stem cells (rBMSC) and materials extraction liquid. Observation of the morphological changes in rBMSC in culture at time points of 3, 5, and 7 days, the use of the MTT assay, and determination of the relative growth in the above set of rBMSC in cell culture at 3, 5, and 7 days, to judge the material's cytotoxicity.RESULTS: With time, the absorbance value of the three groups of cells were significantly increased (P < 0.01). The relative growth of the rBMSCs in experimental group in the first 3, 5, and 7 days was 95.3%, 96.8% and 97.6%; the cytotoxicity was according to the national standards I; the difference was not significant (P > 0.05) between the the experimental group and the negative control group; there was a significant difference between the positive control group and the other 2 groups (P < 0.05). Cells in the experimental group were seen having normal morphology, and spindle-shaped adherent growth.CONCLUSION: PLA composite artificial bone materials and Nano-HA show good cell compatibility, and the values for cytotoxicity, with reference to GB/T16886.5.2003 (China) standards, are in the safe range.

Cytocompatibility Evaluation of PLA-P8 5-PLA Nanoparticles in Vitro

Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles in Vitro and in Vivo

Biocompatibility Assessment Of Dnr-Peg-Pll-Plga Nanoparticles In Vitro And In Vivo

Cytocompatibility of PLA/Nano-HA composites for interface fixation

Study on Uptake of PLA-Pluronic P85-PLA Nanoparticles with Caco-2 Cells

Novel Strategy to Fabricate PLA/Au Nanocomposites As an Efficient Drug Carrier for Human Leukemia Cells in Vitro

In Vitro Evaluation of the Genotoxicity of a Family of Novel MeO-PEG-poly(D,L-lactic-co-glycolic Acid)-Peg-ome Triblock Copolymer and PLGA Nanoparticles.

The Research On Cytotoxicity And Cellular Uptake Of Mpeg-Plga-Pll Nanoparticles

In vitro and in vivo evaluation of immune response of poly(lactic acid) nanoparticles with different end groups

Chemosensitivity of Tca8113 and BcaCD885 Cell Lines to Cisplatin Loaded Polylactic Acid-polyethylene Glycol Nanoparticles for Targeting Oral Carcinoma.

Biocompatibility of electrospun carbon nanotubes/poly(L-lactic acid) nanofiber scaffolds with mouse neural stem cells

Electrospun PLLA and PLLA/HA nanofiber:comparison of their cytocompatibility in vitro

Biocompatibility Studies on Porous PLGA/HA

Preparation and Cytocompatibility of Chitosan‐modified Polylactide

Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles

Study on the Biocompatibility and Degradation Behavior of Polyl(l-lactide-co-glycolide) in Vitro and in Vivo

Biocompatibility of Poly(l-Lactide)/poly(l-lactide) Surface Grafted Hydroxyapatite Composite

Antitumor Effect of Poly Lactic Acid Nanoparticles Loaded with Cisplatin and Chloroquine on the Oral Squamous Cell Carcinoma

Evaluation of the Biological Response of Chang Cells to PELGE Nanoparticles: Study on C - Fos, C - Myc, and P53 Mrna Expression

Acute toxicity study of cisplatin loaded polylactic acid-polyethylene glycol nanoparticles for targeting oral carcinoma

Preparation and Cytocompatibility of Novel Nano-HA/PLA Composite